Corona Prandi , B., M. P Rosim, G. Ogata Pedro, e M. Papadimitropoulos. “Cost Per Number Needed to Treat and Treatment Cost of Baricitinib Versus Adalimumab on Rheumatoid Arthritis Treatment in the Brazilian Private Healthcare System”. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA, vol. 4, nº s.1, fevereiro de 2023, doi:10.22563/2525-7323.2019.v4.s1.p.117.